Alexander Introduces Pharmaceutical Compounding Legislation

Wednesday, May 15, 2013

Chairman of the Senate Health, Education, Labor and Pensions Committee Senator Tom Harkin (D-Iowa) and Ranking Member Lamar Alexander (R-Tn.), with Senators Pat Roberts (R-Ks.) and Al Franken (D-Mn.) and other members of the HELP Committee, on Wednesday introduced legislation—the Pharmaceutical Compounding Quality and Accountability Act—that would improve the safety of compounded human and animal drugs by making clear the compounding oversight responsibilities of state and federal authorities. 

Chairman Harkin and Ranking Member Alexander also announced that the Committee will convene for an executive session next Wednesday, to consider the compounding bill, along with newly-introduced legislation to strengthen and improve the drug distribution supply chain.

In April, Senators Harkin, Alexander, Roberts, and Franken released draft legislation relating to pharmaceutical compounding and requested that stakeholders provide feedback on the policy merits, potential unintended consequences, and opportunities to improve the legislative language. Additionally, the HELP Committee held a legislative hearing in early May to listen to more in-depth testimonies from experts and stakeholders to improve the draft bill.  An updated one-pager, section-by-section and the Pharmaceutical Compounding Quality and Accountability Act can be viewed on the HELP Committee website.

The Pharmaceutical Compounding Quality and Accountability Act makes a clear distinction between traditional compounding—which will continue to be regulated primarily by state pharmacy boards—and compounding manufacturers that make sterile products without, or in advance of, a prescription and sell those products across state lines. The compounding manufacturers would be regulated by the U.S. Food and Drug Administration (FDA). It clarifies a national, uniform set of rules for compounding manufacturers while preserving the states’ primary role in traditional pharmacy regulation.

“We cannot wait for the next public health crisis—as we saw with the New England Compounding Company disaster that led to more than 50 deaths and caused serious illness in 700 more—to act to improve the safety of compounded drugs,” Chairman Harkin said. “The Pharmaceutical Compounding Quality and Accountability Act will help protect the public from unsafe compounded products and clarify FDA authority over high-risk compounding practices. I am proud of the bipartisan effort that members of this Committee have put forth in drafting this bill, and I am appreciative of the helpful and constructive feedback received from stakeholders throughout this process. I look forward to considering this bill in an executive session of the Committee next week.”

Senator Alexander said, “My primary goal with this legislation is to erase the confusion over who regulates pharmacies and manufacturing facilities, and make it clear exactly who oversees each business. Putting one agency on the flagpole for each of these businesses will mean greater safety for American families, so they don’t have to question whether the drugs they take are safe.”

“I am proud of the work we have done to craft a solution that protects patients, while preserving the practice of traditional pharmacy compounding,” Senator Roberts said. “After reviewing stakeholder comments, we made a concerted effort to address their concerns in this legislation. This bipartisan bill is balanced, clear and will leave no questions about the regulatory oversight of compounded drugs. I urge my colleagues to support it.”

"We've seen far too many deaths in Minnesota, and nationwide, because some pharmacies in this country have acted more like drug manufacturers – without following rigorous safety rules that drug manufacturers must follow,” said Senator Franken. “This bipartisan legislation will keep Minnesotans safe by ensuring that drug manufacturers have appropriate oversight, and that responsible pharmacies don't see any unnecessary restrictions."

In addition to distinguishing between pharmacies and manufacturers, and clarifying proper oversight of each, the legislation sets forth requirements on compounding manufacturers. Compounding manufacturers must register with the FDA and tell the agency what products they have made; make products under a pharmacist’s oversight and in compliance with good manufacturing practices; and investigate and report when things go wrong.

The bill allows FDA to identify categories of drugs that currently cannot be safely compounded; preserves and enhances current protections regarding the ingredients from which drugs are compounded; and preserves the line between compounding manufacturers and traditional manufacturers by placing prohibitions on wholesale distribution of compounded products.

The legislation also encourages communication among states and increases communication between states and the FDA. FDA will designate a point of contact for a State Board of Pharmacy to notify the agency if it appears that a state-licensed business should be registered as a compounding pharmacy. The FDA must notify the state within 15 days if it determines that business is a compounding manufacturer.



Morning Pointe Residents Bond With Boyd Buchanan Students

The 2018 Olympics is over, but a group of students at Boyd Buchanan enjoyed keeping their version of the games going at Morning Pointe of Hixson.   The youth hosted a variety of activities for the residents at the assisted living and Alzheimer's memory care community, such as bowling, chair volleyball and a hula hoop contest, to name a few.    "It was a day ... (click for more)

Mark Kimball Named CEO Of Erlanger Murphy Medical Center

Mark Kimball, FACHE, has been named chief executive officer of Erlanger Murphy Medical Center, based in Murphy, N.C.  The announcement was made this week by Kevin M. Spiegel, FACHE, president & CEO of the Erlanger Health System.  The North Carolina-based healthcare facility became Erlanger’s sixth hospital on April 1 and its first in North Carolina.   When ... (click for more)

Robert Gillisse Was Pilot Killed In Plane Crash At Collegedale Airport

The pilot who was killed in a plane crash on the runway of the Collegedale Airport on Friday evening has been identified as Robert Gillisse, 62, of Ooltewah . Charles Swain, who is the director of the airport, said the plane was a total loss. It was a single-occupant plane. He said the plane was taking off when it crashed. He said Mr. Gillisse frequently had flown out of ... (click for more)

East Ridge To Build Open-Air Pavilion Near City Hall

East Ridge plans to construct an open-air pavilion that will include restrooms and a concession area near City Hall and the old McBrien School.  It will be part of a Town Center for East Ridge at the Tombras Avenue property. The city is also applying for a $500,000 grant to help convert Pioneer Park into a refurbished park with a splash pad. The firm of Hefferlin and ... (click for more)

A Tribute For My Brother – Sgt. Jonathan Gardner, U.S. Army

Seven years ago today, my family and I found out that my brother, Sgt. Jonathan D. Gardner, was seriously injured by a roadside bomb, (explosively formed penetrator - EFP), while on a mission in Kuwait. The EFP went through the bottom of his seat and put a softball size hole in his upper thigh. The doctors said that if the bomb had entered the Humvee an inch to the right, he ... (click for more)

Roy Exum: The Saturday Funnies

All of us who marvel at the sound of bagpipes at a funeral realize the majesty that people like piper Scottie Maclellan can lend to any “homecoming” and for years there has been a wonderful tale out of Nova Scotia that leads this week’s parade of The  Saturday  Funnies. Mind you, I do not write these stories, as many who have followed man’s laughter down through the ... (click for more)